ImageneBio, Inc. Share Price
NASDAQ: IMA | Micro CapImageneBio, Inc. Stock Performance
ImageneBio, Inc. Share Price Today
As of 30 October 2026, ImageneBio, Inc.'s share price is $4.22. The stock opened at $4.18, compared to its previous close of $4.05. During today's trading session, ImageneBio, Inc.'s share price traded between $4.18 and $4.18, with an average price of $4.18. Over the past 52 weeks, the stock has recorded a high of $9.01 and a low of $4.01. In terms of performance, ImageneBio, Inc.'s share price has declined by 30.25% over the last six months and is down 50.87% on a year-on-year basis.
ImageneBio, Inc. Share Price Chart
ImageneBio, Inc. Quarterly Profit & Loss
All figures in USD
ImageneBio, Inc. Annual Profit & Loss
All figures in USD
About ImageneBio, Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
ImageneBio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.58 | $4.18 | -15.47% |
Sep 2026 | $4.96 | $4.95 | -10.50% |
Aug 2026 | $5.33 | $5.53 | -3.07% |
Jul 2026 | $5.81 | $5.70 | -6.25% |
Jun 2026 | $5.56 | $6.08 | +3.40% |
May 2026 | $5.89 | $5.88 | -2.81% |
Apr 2026 | $4.96 | $6.05 | +26.30% |
Mar 2026 | $6.24 | $4.79 | -31.47% |
Feb 2026 | $7.23 | $6.99 | -6.68% |
Jan 2026 | $6.87 | $7.49 | +9.02% |
Dec 2025 | $6.71 | $6.87 | -3.24% |
Nov 2025 | $8.30 | $7.10 | -17.35% |